Share Price and Basic Stock Data
Last Updated: January 21, 2026, 3:21 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cella Space Ltd operates in the Paper & Paper Products industry, with a current market capitalization of ₹26.9 Cr. The company’s share price stands at ₹13.4, reflecting a price-to-earnings (P/E) ratio of 28.0. Revenue trends indicate a consistent upward trajectory, with sales increasing from ₹2.69 Cr in March 2020 to ₹7.41 Cr in March 2023. The trailing twelve months (TTM) sales have further risen to ₹7.66 Cr. Quarterly sales figures show that the most recent quarter ending December 2023 reported ₹1.92 Cr, showing a steady recovery from a pandemic-induced slump. The company’s operating profit margin (OPM) was notably high at 74.48% in December 2023, demonstrating strong operational efficiency and cost management. The company is positioned to capitalize on the growing demand within the paper products sector, which has been bolstered by sustainability trends and increased consumption. However, the company’s historical volatility in sales and the absence of foreign institutional investor (FII) interest raises concerns regarding long-term investor confidence.
Profitability and Efficiency Metrics
Cella Space Ltd’s profitability metrics reveal a mixed performance. The operating profit for the fiscal year ending March 2023 stood at ₹4.97 Cr, with an operating profit margin of 67.07%, indicating robust operational efficiency. However, net profit for the same period was ₹1.13 Cr, resulting in a net profit margin of 15.24%, which is lower compared to previous years, where it was 19.30% in March 2022. The interest coverage ratio (ICR) stood at 1.97x, suggesting that while the company can meet its interest obligations, the margin for error is slim. Additionally, the return on capital employed (ROCE) improved to 10.73% in March 2023, reflecting better utilization of capital. Despite these strengths, the company has reported negative return on equity (ROE) of -5.34% in March 2023, indicating challenges in generating returns for shareholders. The fluctuating quarterly net profit figures, particularly the decline to ₹0.17 Cr in September 2023, highlight potential operational risks that may affect future profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Cella Space Ltd reflects significant challenges, particularly with a negative reserve of ₹40.84 Cr as of December 2023. Total borrowings were reported at ₹57.58 Cr, indicating a high reliance on debt financing, which is concerning given the company’s current ratio of only 0.23x. This low liquidity position may hinder the company’s ability to meet short-term obligations. The price-to-book value (P/BV) ratio stood at -0.81x, illustrating that the market values the company less than its actual net asset value, which could deter potential investors. The company’s total liabilities were ₹43.35 Cr against total assets of ₹43.95 Cr, suggesting a precarious financial position. The long-term debt-to-equity ratio of -1.88x indicates that the company is heavily leveraged, which is a red flag for investors. Nevertheless, the interest coverage ratio of 1.97x suggests that the company can cover its interest expenses, albeit with limited capacity, emphasizing the need for improved financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cella Space Ltd indicates a stable ownership structure, with promoters holding 58.50% of the shares as of December 2023. This substantial promoter holding can instill confidence among investors regarding the company’s governance. The public shareholding stood at 41.50%, with the total number of shareholders recorded at 7,356. The stability in the promoter’s stake over recent quarters suggests a commitment to the company’s long-term strategy. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) raises concerns about the stock’s attractiveness to larger institutional players, which could limit liquidity and price appreciation. Moreover, the fluctuating number of shareholders, which declined from 7,562 in March 2023 to 7,457 in December 2023, indicates a potential erosion of investor interest, further complicating the company’s path to recovery and growth.
Outlook, Risks, and Final Insight
The outlook for Cella Space Ltd is contingent on its ability to navigate several operational and financial risks. The company’s high operating profit margins suggest potential for profitability, yet the negative ROE and high leverage pose significant risks. Should the company manage to stabilize its revenue streams and improve its financial health, it could attract institutional investment and enhance shareholder value. Conversely, persistent losses coupled with negative reserves may lead to further scrutiny from investors and regulators. The potential for growth exists if Cella Space Ltd can capitalize on the sustainable trends in the paper products sector, but the company must address its liquidity issues and negative equity position to reassure stakeholders. Overall, while the company shows promise in certain operational metrics, significant risks remain that could impede its growth trajectory in the competitive landscape of the paper industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mohit Paper Mills Ltd | 39.6 Cr. | 28.3 | 39.9/25.4 | 6.20 | 39.0 | 0.00 % | 12.0 % | 13.6 % | 10.0 |
| Gratex Industries Ltd | 5.50 Cr. | 18.2 | 26.2/14.2 | 50.0 | 12.2 | 0.00 % | 3.85 % | 2.52 % | 10.0 |
| Ganga Papers India Ltd | 87.1 Cr. | 80.8 | 114/75.1 | 57.7 | 29.0 | 0.00 % | 6.44 % | 5.19 % | 10.0 |
| Encode Packaging India Ltd | 3.48 Cr. | 11.0 | 19.0/10.6 | 10.3 | 0.00 % | 2.06 % | 2.12 % | 10.0 | |
| Cella Space Ltd | 26.8 Cr. | 13.3 | 19.3/9.11 | 27.9 | 10.3 | 0.00 % | 10.7 % | % | 10.0 |
| Industry Average | 706.64 Cr | 72.41 | 43.30 | 107.44 | 0.77% | 9.32% | 134.80% | 6.50 |
Quarterly Result
| Metric | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.16 | 1.37 | 1.22 | 1.25 | 1.27 | 1.61 | 1.90 | 1.76 | 1.74 | 2.01 | 1.85 | 1.88 | 1.92 |
| Expenses | 0.33 | 0.63 | 0.21 | 0.27 | 0.27 | 0.96 | 0.52 | 0.55 | 0.54 | 0.83 | 0.43 | 0.50 | 0.49 |
| Operating Profit | 0.83 | 0.74 | 1.01 | 0.98 | 1.00 | 0.65 | 1.38 | 1.21 | 1.20 | 1.18 | 1.42 | 1.38 | 1.43 |
| OPM % | 71.55% | 54.01% | 82.79% | 78.40% | 78.74% | 40.37% | 72.63% | 68.75% | 68.97% | 58.71% | 76.76% | 73.40% | 74.48% |
| Other Income | 0.56 | -0.50 | 0.00 | 0.00 | 0.06 | 1.79 | 0.09 | 0.09 | 0.10 | 0.13 | 0.11 | 0.09 | 0.04 |
| Interest | 0.44 | 0.50 | 0.94 | 0.85 | 0.74 | 0.75 | 0.75 | 0.70 | 0.66 | 0.63 | 0.94 | 0.93 | 0.92 |
| Depreciation | 0.21 | 0.30 | 0.32 | 0.31 | 0.32 | 0.24 | 0.37 | 0.37 | 0.36 | 0.39 | 0.37 | 0.37 | 0.37 |
| Profit before tax | 0.74 | -0.56 | -0.25 | -0.18 | 0.00 | 1.45 | 0.35 | 0.23 | 0.28 | 0.29 | 0.22 | 0.17 | 0.18 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.34% | 0.00% | 0.00% | 0.00% | |
| Net Profit | 0.74 | -0.56 | -0.25 | -0.18 | 0.01 | 1.45 | 0.35 | 0.23 | 0.29 | 0.26 | 0.22 | 0.17 | 0.18 |
| EPS in Rs | 0.39 | -0.28 | -0.13 | -0.09 | 0.01 | 0.76 | 0.17 | 0.11 | 0.14 | 0.13 | 0.11 | 0.09 | 0.09 |
Last Updated: February 28, 2025, 12:40 pm
Below is a detailed analysis of the quarterly data for Cella Space Ltd based on the most recent figures (Dec 2023) and their trends compared to the previous period:
- For Sales, as of Dec 2023, the value is 1.92 Cr.. The value appears strong and on an upward trend. It has increased from 1.88 Cr. (Sep 2023) to 1.92 Cr., marking an increase of 0.04 Cr..
- For Expenses, as of Dec 2023, the value is 0.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.50 Cr. (Sep 2023) to 0.49 Cr., marking a decrease of 0.01 Cr..
- For Operating Profit, as of Dec 2023, the value is 1.43 Cr.. The value appears strong and on an upward trend. It has increased from 1.38 Cr. (Sep 2023) to 1.43 Cr., marking an increase of 0.05 Cr..
- For OPM %, as of Dec 2023, the value is 74.48%. The value appears strong and on an upward trend. It has increased from 73.40% (Sep 2023) to 74.48%, marking an increase of 1.08%.
- For Other Income, as of Dec 2023, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Sep 2023) to 0.04 Cr., marking a decrease of 0.05 Cr..
- For Interest, as of Dec 2023, the value is 0.92 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.93 Cr. (Sep 2023) to 0.92 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Dec 2023, the value is 0.37 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded 0.37 Cr..
- For Profit before tax, as of Dec 2023, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Sep 2023) to 0.18 Cr., marking an increase of 0.01 Cr..
- For Tax %, as of Dec 2023, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded 0.00%.
- For Net Profit, as of Dec 2023, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.17 Cr. (Sep 2023) to 0.18 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Dec 2023, the value is 0.09. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 15, 2025, 4:04 am
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 196.70 | 203.77 | 202.44 | 154.04 | 99.49 | 27.54 | 1.52 | 0.00 | 2.69 | 3.28 | 5.34 | 7.41 | 7.66 |
| Expenses | 176.02 | 184.95 | 190.00 | 152.18 | 105.30 | 64.28 | 3.14 | 4.90 | 2.47 | 1.37 | 1.70 | 2.44 | 2.25 |
| Operating Profit | 20.68 | 18.82 | 12.44 | 1.86 | -5.81 | -36.74 | -1.62 | -4.90 | 0.22 | 1.91 | 3.64 | 4.97 | 5.41 |
| OPM % | 10.51% | 9.24% | 6.15% | 1.21% | -5.84% | -133.41% | -106.58% | 8.18% | 58.23% | 68.16% | 67.07% | 70.63% | |
| Other Income | -0.44 | 0.42 | 0.78 | -7.44 | -2.18 | 1.14 | -5.90 | 7.17 | 2.58 | 0.66 | 0.20 | 0.41 | 0.37 |
| Interest | 5.74 | 7.16 | 6.86 | 5.90 | 6.45 | 5.71 | 2.14 | 0.08 | 1.61 | 1.41 | 1.63 | 2.74 | 3.42 |
| Depreciation | 4.32 | 5.03 | 4.90 | 3.77 | 3.18 | 1.38 | 0.73 | 0.57 | 0.43 | 0.82 | 1.18 | 1.48 | 1.50 |
| Profit before tax | 10.18 | 7.05 | 1.46 | -15.25 | -17.62 | -42.69 | -10.39 | 1.62 | 0.76 | 0.34 | 1.03 | 1.16 | 0.86 |
| Tax % | 35.76% | 33.33% | 19.18% | -22.89% | -3.80% | -13.73% | -26.08% | -17.28% | 0.00% | 0.00% | 0.00% | 2.59% | |
| Net Profit | 6.54 | 4.71 | 1.18 | -11.76 | -16.95 | -36.83 | -7.68 | 1.89 | 0.76 | 0.33 | 1.03 | 1.13 | 0.83 |
| EPS in Rs | 4.00 | 2.86 | 0.71 | -7.16 | -10.31 | -22.41 | -4.44 | 1.04 | 0.42 | 0.19 | 0.54 | 0.56 | 0.42 |
| Dividend Payout % | 52.55% | 52.47% | 84.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -27.98% | -74.95% | -1096.61% | -44.13% | -117.29% | 79.15% | 124.61% | -59.79% | -56.58% | 212.12% | 9.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -46.97% | -1021.66% | 1052.48% | -73.15% | 196.43% | 45.46% | -184.40% | 3.21% | 268.70% | -202.41% |
Cella Space Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -28% |
| 5 Years: | 37% |
| 3 Years: | 40% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -33% |
| 3 Years: | 44% |
| TTM: | 43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 29% |
| 3 Years: | 27% |
| 1 Year: | 15% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: September 10, 2025, 3:19 pm
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 17.30 | 18.20 | 19.15 | 19.15 | 19.15 | 20.15 | 20.15 |
| Reserves | 25.67 | 27.48 | 27.49 | 15.10 | -1.85 | -39.08 | -44.32 | -43.30 | -43.75 | -43.44 | -42.41 | -41.25 | -40.84 |
| Borrowings | 47.72 | 43.37 | 45.19 | 48.76 | 42.81 | 53.35 | 33.51 | 26.58 | 39.09 | 49.36 | 59.32 | 57.54 | 57.58 |
| Other Liabilities | 48.87 | 46.92 | 49.81 | 39.47 | 36.38 | 11.72 | 10.69 | 9.34 | 5.40 | 4.61 | 8.22 | 7.51 | 6.46 |
| Total Liabilities | 138.70 | 134.21 | 138.93 | 119.77 | 93.78 | 42.43 | 17.18 | 10.82 | 19.89 | 29.68 | 44.28 | 43.95 | 43.35 |
| Fixed Assets | 74.73 | 74.51 | 71.45 | 58.36 | 55.03 | 9.66 | 7.70 | 9.39 | 9.25 | 26.75 | 39.42 | 39.15 | 38.43 |
| CWIP | 0.16 | 0.02 | 0.17 | 0.18 | 0.23 | 0.00 | 0.00 | 0.00 | 9.02 | 1.73 | 0.33 | 0.00 | 0.00 |
| Investments | 0.74 | 0.74 | 0.74 | 0.74 | 0.53 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 63.07 | 58.94 | 66.57 | 60.49 | 37.99 | 32.75 | 9.46 | 1.42 | 1.61 | 1.19 | 4.52 | 4.79 | 4.91 |
| Total Assets | 138.70 | 134.21 | 138.93 | 119.77 | 93.78 | 42.43 | 17.18 | 10.82 | 19.89 | 29.68 | 44.28 | 43.95 | 43.35 |
Below is a detailed analysis of the balance sheet data for Cella Space Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2023, the value is 20.15 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 20.15 Cr..
- For Reserves, as of Sep 2023, the value is -40.84 Cr.. The value appears to be improving (becoming less negative). It has improved from -41.25 Cr. (Mar 2023) to -40.84 Cr., marking an improvement of 0.41 Cr..
- For Borrowings, as of Sep 2023, the value is 57.58 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 57.54 Cr. (Mar 2023) to 57.58 Cr., marking an increase of 0.04 Cr..
- For Other Liabilities, as of Sep 2023, the value is 6.46 Cr.. The value appears to be improving (decreasing). It has decreased from 7.51 Cr. (Mar 2023) to 6.46 Cr., marking a decrease of 1.05 Cr..
- For Total Liabilities, as of Sep 2023, the value is 43.35 Cr.. The value appears to be improving (decreasing). It has decreased from 43.95 Cr. (Mar 2023) to 43.35 Cr., marking a decrease of 0.60 Cr..
- For Fixed Assets, as of Sep 2023, the value is 38.43 Cr.. The value appears to be declining and may need further review. It has decreased from 39.15 Cr. (Mar 2023) to 38.43 Cr., marking a decrease of 0.72 Cr..
- For CWIP, as of Sep 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
- For Investments, as of Sep 2023, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.01 Cr..
- For Other Assets, as of Sep 2023, the value is 4.91 Cr.. The value appears strong and on an upward trend. It has increased from 4.79 Cr. (Mar 2023) to 4.91 Cr., marking an increase of 0.12 Cr..
- For Total Assets, as of Sep 2023, the value is 43.35 Cr.. The value appears to be declining and may need further review. It has decreased from 43.95 Cr. (Mar 2023) to 43.35 Cr., marking a decrease of 0.60 Cr..
However, the Borrowings (57.58 Cr.) are higher than the Reserves (-40.84 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -27.04 | -24.55 | -32.75 | -46.90 | -48.62 | -90.09 | -35.13 | -31.48 | -38.87 | -47.45 | -55.68 | -52.57 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46.84 | 54.20 | 64.76 | 61.47 | 61.05 | 44.27 | 429.84 | 20.35 | 36.72 | 25.29 | 26.60 | |
| Inventory Days | 61.78 | 33.03 | 43.20 | 66.20 | 56.43 | 15.02 | 0.00 | |||||
| Days Payable | 61.78 | 59.56 | 67.10 | 65.52 | 102.24 | 81.88 | ||||||
| Cash Conversion Cycle | 46.84 | 27.67 | 40.86 | 62.14 | 15.24 | -22.59 | 429.84 | 20.35 | 36.72 | 25.29 | 26.60 | |
| Working Capital Days | -21.34 | -9.58 | -3.05 | -9.34 | -66.95 | -160.37 | -5,746.35 | -3,218.51 | -1,268.60 | -587.83 | -438.39 | |
| ROCE % | 20.77% | 16.22% | 9.44% | -1.01% | -11.91% | -83.83% | 40.49% | -37.11% | 5.30% | 8.81% | 8.68% | 10.73% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.56 | 0.54 | 0.17 | 0.41 | 1.04 |
| Diluted EPS (Rs.) | 0.56 | 0.54 | 0.17 | 0.41 | 0.98 |
| Cash EPS (Rs.) | 1.29 | 1.16 | 0.60 | 0.62 | 1.36 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -10.43 | -12.10 | -12.64 | -12.79 | -13.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -10.43 | -12.10 | -12.64 | -12.79 | -13.70 |
| Revenue From Operations / Share (Rs.) | 3.67 | 2.79 | 1.71 | 1.40 | 0.00 |
| PBDIT / Share (Rs.) | 2.67 | 2.01 | 1.34 | 0.44 | -0.52 |
| PBIT / Share (Rs.) | 1.94 | 1.39 | 0.90 | 0.22 | -0.84 |
| PBT / Share (Rs.) | 0.57 | 0.53 | 0.17 | 0.39 | 0.88 |
| Net Profit / Share (Rs.) | 0.56 | 0.53 | 0.17 | 0.39 | 1.04 |
| NP After MI And SOA / Share (Rs.) | 0.56 | 0.53 | 0.18 | 0.42 | 1.04 |
| PBDIT Margin (%) | 72.71 | 71.96 | 78.19 | 31.84 | 0.00 |
| PBIT Margin (%) | 52.70 | 49.80 | 53.14 | 15.84 | 0.00 |
| PBT Margin (%) | 15.70 | 19.30 | 10.20 | 28.23 | 0.00 |
| Net Profit Margin (%) | 15.24 | 19.30 | 10.18 | 28.23 | 0.00 |
| NP After MI And SOA Margin (%) | 15.24 | 19.32 | 10.94 | 30.13 | 0.00 |
| Return on Networth / Equity (%) | -5.34 | -4.43 | -1.47 | -3.29 | -7.57 |
| Return on Capital Employeed (%) | 12.05 | 7.79 | 10.00 | -9.55 | 11.09 |
| Return On Assets (%) | 2.56 | 2.32 | 1.20 | 4.07 | 17.58 |
| Long Term Debt / Equity (X) | -1.88 | -1.81 | -1.12 | -0.28 | 0.00 |
| Total Debt / Equity (X) | -2.27 | -2.10 | -1.47 | -1.11 | -0.63 |
| Asset Turnover Ratio (%) | 0.16 | 0.14 | 0.13 | 0.17 | 0.00 |
| Current Ratio (X) | 0.23 | 0.28 | 0.07 | 0.05 | 0.05 |
| Quick Ratio (X) | 0.23 | 0.28 | 0.07 | 0.05 | 0.05 |
| Interest Coverage Ratio (X) | 1.97 | 2.36 | 1.82 | 0.53 | -11.81 |
| Interest Coverage Ratio (Post Tax) (X) | 1.41 | 1.63 | 1.24 | 0.26 | -15.48 |
| Enterprise Value (Cr.) | 74.72 | 71.81 | 57.68 | 43.90 | 36.62 |
| EV / Net Operating Revenue (X) | 10.09 | 13.45 | 17.60 | 16.33 | 0.00 |
| EV / EBITDA (X) | 13.88 | 18.69 | 22.50 | 51.27 | -37.99 |
| MarketCap / Net Operating Revenue (X) | 2.32 | 2.56 | 3.17 | 2.19 | 0.00 |
| Price / BV (X) | -0.81 | -0.58 | -0.42 | -0.23 | -0.40 |
| Price / Net Operating Revenue (X) | 2.32 | 2.57 | 3.17 | 2.19 | 0.00 |
| EarningsYield | 0.06 | 0.07 | 0.03 | 0.13 | 0.18 |
After reviewing the key financial ratios for Cella Space Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 0.56. This value is below the healthy minimum of 5. It has increased from 0.54 (Mar 22) to 0.56, marking an increase of 0.02.
- For Diluted EPS (Rs.), as of Mar 23, the value is 0.56. This value is below the healthy minimum of 5. It has increased from 0.54 (Mar 22) to 0.56, marking an increase of 0.02.
- For Cash EPS (Rs.), as of Mar 23, the value is 1.29. This value is below the healthy minimum of 3. It has increased from 1.16 (Mar 22) to 1.29, marking an increase of 0.13.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -10.43. It has increased from -12.10 (Mar 22) to -10.43, marking an increase of 1.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is -10.43. It has increased from -12.10 (Mar 22) to -10.43, marking an increase of 1.67.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 3.67. It has increased from 2.79 (Mar 22) to 3.67, marking an increase of 0.88.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 2.67. This value is within the healthy range. It has increased from 2.01 (Mar 22) to 2.67, marking an increase of 0.66.
- For PBIT / Share (Rs.), as of Mar 23, the value is 1.94. This value is within the healthy range. It has increased from 1.39 (Mar 22) to 1.94, marking an increase of 0.55.
- For PBT / Share (Rs.), as of Mar 23, the value is 0.57. This value is within the healthy range. It has increased from 0.53 (Mar 22) to 0.57, marking an increase of 0.04.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 0.56. This value is below the healthy minimum of 2. It has increased from 0.53 (Mar 22) to 0.56, marking an increase of 0.03.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 0.56. This value is below the healthy minimum of 2. It has increased from 0.53 (Mar 22) to 0.56, marking an increase of 0.03.
- For PBDIT Margin (%), as of Mar 23, the value is 72.71. This value is within the healthy range. It has increased from 71.96 (Mar 22) to 72.71, marking an increase of 0.75.
- For PBIT Margin (%), as of Mar 23, the value is 52.70. This value exceeds the healthy maximum of 20. It has increased from 49.80 (Mar 22) to 52.70, marking an increase of 2.90.
- For PBT Margin (%), as of Mar 23, the value is 15.70. This value is within the healthy range. It has decreased from 19.30 (Mar 22) to 15.70, marking a decrease of 3.60.
- For Net Profit Margin (%), as of Mar 23, the value is 15.24. This value exceeds the healthy maximum of 10. It has decreased from 19.30 (Mar 22) to 15.24, marking a decrease of 4.06.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 15.24. This value is within the healthy range. It has decreased from 19.32 (Mar 22) to 15.24, marking a decrease of 4.08.
- For Return on Networth / Equity (%), as of Mar 23, the value is -5.34. This value is below the healthy minimum of 15. It has decreased from -4.43 (Mar 22) to -5.34, marking a decrease of 0.91.
- For Return on Capital Employeed (%), as of Mar 23, the value is 12.05. This value is within the healthy range. It has increased from 7.79 (Mar 22) to 12.05, marking an increase of 4.26.
- For Return On Assets (%), as of Mar 23, the value is 2.56. This value is below the healthy minimum of 5. It has increased from 2.32 (Mar 22) to 2.56, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 23, the value is -1.88. This value is below the healthy minimum of 0.2. It has decreased from -1.81 (Mar 22) to -1.88, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 23, the value is -2.27. This value is within the healthy range. It has decreased from -2.10 (Mar 22) to -2.27, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.16. It has increased from 0.14 (Mar 22) to 0.16, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 23, the value is 0.23. This value is below the healthy minimum of 1.5. It has decreased from 0.28 (Mar 22) to 0.23, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 23, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 22) to 0.23, marking a decrease of 0.05.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 1.97. This value is below the healthy minimum of 3. It has decreased from 2.36 (Mar 22) to 1.97, marking a decrease of 0.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.63 (Mar 22) to 1.41, marking a decrease of 0.22.
- For Enterprise Value (Cr.), as of Mar 23, the value is 74.72. It has increased from 71.81 (Mar 22) to 74.72, marking an increase of 2.91.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 10.09. This value exceeds the healthy maximum of 3. It has decreased from 13.45 (Mar 22) to 10.09, marking a decrease of 3.36.
- For EV / EBITDA (X), as of Mar 23, the value is 13.88. This value is within the healthy range. It has decreased from 18.69 (Mar 22) to 13.88, marking a decrease of 4.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.32. This value is within the healthy range. It has decreased from 2.56 (Mar 22) to 2.32, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 23, the value is -0.81. This value is below the healthy minimum of 1. It has decreased from -0.58 (Mar 22) to -0.81, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.32. This value is within the healthy range. It has decreased from 2.57 (Mar 22) to 2.32, marking a decrease of 0.25.
- For EarningsYield, as of Mar 23, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 22) to 0.06, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cella Space Ltd:
- Net Profit Margin: 15.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.05% (Industry Average ROCE: 9.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.34% (Industry Average ROE: 134.8%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.23
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.9 (Industry average Stock P/E: 43.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paper & Paper Products | 57/2993,Sree Kailas Paliam Road, Cochin Kerala 682016 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. N Subramanian | Chairman(NonExe.&Ind.Director) |
| Mr. S Rajkumar | Vice Chairman & Mng.Director |
| Mr. Kul Bhushan Jain | Ind. Non-Executive Director |
| Mr. Akhilesh Agarwal | Ind. Non-Executive Director |
| Mr. V Manoharan | Ind. Non-Executive Director |
| Mr. Visakh Rajkumar | Non-Executive Promoter Director |
| Mrs. Rajee Rajkumar | Non-Executive Promoter Director |
| Mr. S Subramoniam | Non-Executive Promoter Director |
| Mrs. E Kamalam | Non-Executive Promoter Director |
FAQ
What is the intrinsic value of Cella Space Ltd?
Cella Space Ltd's intrinsic value (as of 21 January 2026) is ₹35.17 which is 164.44% higher the current market price of ₹13.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹26.8 Cr. market cap, FY2025-2026 high/low of ₹19.3/9.11, reserves of ₹-40.84 Cr, and liabilities of ₹43.35 Cr.
What is the Market Cap of Cella Space Ltd?
The Market Cap of Cella Space Ltd is 26.8 Cr..
What is the current Stock Price of Cella Space Ltd as on 21 January 2026?
The current stock price of Cella Space Ltd as on 21 January 2026 is ₹13.3.
What is the High / Low of Cella Space Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cella Space Ltd stocks is ₹19.3/9.11.
What is the Stock P/E of Cella Space Ltd?
The Stock P/E of Cella Space Ltd is 27.9.
What is the Book Value of Cella Space Ltd?
The Book Value of Cella Space Ltd is 10.3.
What is the Dividend Yield of Cella Space Ltd?
The Dividend Yield of Cella Space Ltd is 0.00 %.
What is the ROCE of Cella Space Ltd?
The ROCE of Cella Space Ltd is 10.7 %.
What is the ROE of Cella Space Ltd?
The ROE of Cella Space Ltd is %.
What is the Face Value of Cella Space Ltd?
The Face Value of Cella Space Ltd is 10.0.